Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Scopus BioPharma Inc. (SCPS) had Weighted-Average Shares Outstanding (Diluted) of 39.74M for the most recently reported fiscal quarter, ending 2023-06-30.
| Income Statement Financials | |
-- |
|
$-2.62M |
|
-- |
|
-- |
|
$2.93M |
|
$-2.93M |
|
-- |
|
$-2.93M |
|
$-2.93M |
|
$-2.93M |
|
$-2.93M |
|
$-2.93M |
|
$-2.93M |
|
$-2.93M |
|
$-2.93M |
|
39.74M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
39.74M |
$-0.07 |
|
$-0.07 |
|
| Balance Sheet Financials | |
$0.50M |
|
$0.00M |
|
$0.00M |
|
$0.50M |
|
$11.00M |
|
-- |
|
-- |
|
$11.00M |
|
$-10.50M |
|
$-10.50M |
|
$-10.50M |
|
39.78M |
|
| Cash Flow Statement Financials | |
$-1.77M |
|
-- |
|
$1.97M |
|
$0.12M |
|
$0.36M |
|
$0.24M |
|
$0.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.05 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.77M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
27.88% |
|
27.88% |
|
-588.65% |
|
27.88% |
|
$-0.26 |
|
$-0.04 |
|
$-0.04 |
|